In an account reported by Daily Mail, Beatrice Aidin describes attempting the diabetes medication Mounjaro (tirzepatide) as a weight-loss treatment. She says she had the medication at home since May but injected it only once. Aidin reports that her first dose of 2.5mg caused nausea. She also says it made her feel “so much more hungry than usual,” which she found contrary to her expectations for appetite control. Because of these effects, she says she did not take another injection. The outlet frames her claims in terms of weight and waist measurements, stating she lost weight and reduced waist size over 21 days, while also describing the medication as a “new diet gel” in the headline. However, in the provided text, her personal experience centers on a single injection rather than ongoing use, and it does not detail a gel regimen. The reporting primarily reflects Aidin’s personal narrative about side effects and her decision to stop after one dose.